Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-835-0 | CAS number: 1310672-91-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-06-29 to 2018-03-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Committee for Proprietary Medicinal Products (CPMP) Note for Guidance on non-clinical local tolerance testing of medicinal products (CPMP/SWP/2145/00)
- Version / remarks:
- adopted 1 March 2001
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- [2-(Isopropoxycarbonyloxy)-benzoyl]-benzoylperoxide
- EC Number:
- 814-835-0
- Cas Number:
- 1310672-91-3
- Molecular formula:
- C18H16O7
- IUPAC Name:
- [2-(Isopropoxycarbonyloxy)-benzoyl]-benzoylperoxide
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- - Batch No.: A-C012967 (Galderma Number) / 854E3F0002 (supplier lot number)
- Purity (HPLC): 99.1%
- Appearance: White Powder
- Expiry date/ reanalysis date: February 28, 2020 / June 20, 2018
- Storage conditions / packaging: Between +2 and +8°C / away from light
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- The RhCE tissues are reconstructed from primary human cells, which have been cultured for several days to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in the human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg - Duration of treatment / exposure:
- 6 hours ± 15 minutes.
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- Post-incubation post-soak plate: 25 ± 2 min at 37 ± 1 °C
Post-incubation post-treatment plate: 18 hours ± 15 minutes at 37 °C, 5% CO2, saturated hygrometry - Number of animals or in vitro replicates:
- 2 tissues per group
- Details on study design:
- Pre-incubation
On the day of receipt, the tissues were equilibrated (in its 24-well shipping container) to room temperature for about 15 minutes. An appropriate volume of EpiOcular™ Assay Medium was warmed to approximately 37 °C. 1 mL of Assay Medium was aliquoted into the appropriate wells of pre-labeled 6-well plates. Each 24-well shipping container was removed from its plastic bag under sterile conditions and its surface disinfected by wiping with ethanol-soaked tissue paper. The sterile gauze was removed and each tissue was inspected for air bubbles between the agarose gel and insert. The tissues were carefully removed from the 24-well shipping containers using sterile forceps. Any agarose adhering to the inserts was removed by gentle blotting on sterile filter paper or gauze. The insert was then transferred aseptically into the 6-well plates and preincubated at standard culture conditions for one hour in the Assay Medium. After one hour, the Assay Medium was replaced by 1 mL of fresh Assay Medium at 37 °C and the EpiOcular™ tissues were incubated at 37 °C, 5% CO2, saturated hygrometry overnight (16 – 24 hours).
Application/Treatment of SOLID test items, control positive and control negative
Pre-Treatment
After the overnight incubation, the tissues were pre-wetted with 20 μL of Ca2+Mg2+free-DPBS. If the Ca2+Mg2+free-DPBS does not spread across the tissues, the plate may be tapped to assure that the entire tissue surface is wetted. The tissues were incubated at 37 °C, 5% CO2, saturated hygrometry for 30 ± 2 minutes.
After the 30 ± 2 minutes Ca2+Mg2+free-DPBS pre-treatment, each solid test and control item was tested by applying 50 mg topically on the EpiOcular™ tissues. The tissues were incubated at standard culture conditions for 6 hours ± 15 minutes. The insert was shaken gently from side to side to ensure that tissue was completely covered by the test item. The test was performed on 2 tissues for the test item, 2 tissues for the negative control and 2 tissues for the positive control. One plate was used per test item, one plate for the control positive and one plate for the control negative to prevent any adjacent effects.
At the end of the 6 hours ± 15 minutes treatment time, the test articles were rinsed. Three clean plastic beakers containing a minimum of 100 ml each of Ca2+Mg2+free DPBS were used per test item. The tissues were rinsed two at a time by holding replicate inserts together by their collar using forceps. The tissues was dipped into the first beaker, swirled in a circular motion in the liquid for approximately 2 seconds, lifted out. This process was performed two additional times in the first beaker, then in the same way in the second and the third beaker.
Post-Soak
After rinsing, the tissues were immediately transferred to and immersed in 5 ml of previously warmed EpiOcular™ Assay Medium (37 °C ± 1 °C) in a pre-labeled 12-well plate for a 25 ± 2 minutes immersion incubation (Post-Soak) at room temperature. This incubation in EpiOcular™Assay Medium was intended to remove any test article absorbed into the tissue.
Post-incubation
At the end of the Post-Soak immersion, each insert was removed from the EpiOcular™ Assay Medium, the medium was decanted off the tissue, and the insert was blotted on absorbent material, and transferred to the appropriate well of the pre-labeled 6-well plate containing 1 ml of warm EpiOcular™ Assay Medium. The tissues were incubated for 18 hours ± 15 minutes at 37 °C, 5% CO2, saturated hygrometry (Post-treatment Incubation).
METHODS FOR MEASURED ENDPOINTS:
Cell viability Measurement
Incubation in MTT solution
After incubation, cell culture inserts were dried on sterile absorbent paper or gauze to remove excess medium. The cell culture inserts were transferred into a 24-wells plate prefilled with 300 μL MTT ready-to-use solution. The tissues were incubated for 3 hours ± 10 minutes at 37 °C, 5% CO2, saturated hygrometry.
Formazan extraction
After incubation the tissues were dried on sterile absorbent paper or gauze. The tissues were transferred in a 6-well plate prefilled with 2 mL of isopropanol. Plates were covered by stretching 3 parafilm layers over the plate to avoid any evaporation and the lid of the plate was added. Plates were then protected from direct light by wrapping in aluminum paper. Two to three hours incubation were performed at room temperature under gentle agitation (about 150 rpm).
Optical Density Measurement
The extraction solution was homogenized by pipetting up and down. Then, 2 x 200 μL of extraction solution was transferred (2 wells per tissue i.e. 2 replicates per tissue) into a 96 well plate. Isopropanol was used as blank (8 replicates). Optical densities (OD) was measured at 570 ± 30 nm using Synergy2 microplate reader (Biotek) and validated Gen5 Secure software (Biotek).
Acceptability of assay
The in vitro eye irritation test was considered acceptable if it meets the following criteria:
- The OD value for the negative control should be > 0.8 with an upper acceptance limit of 2.5
The mean tissue viability of the positive control should be:
- 6 hours exposure ≤ 50% relative to the mean tissue viability of the negative control (which is set at 100%)
- The difference of viability between the two relating tissues of a single chemical is < 20% in the same run (for positive and negative control tissues and tissues of single chemicals).
- The absolute mean OD of the two tissues of the negative control and the positive control should be within the laboratory historical control data range.
Data Evaluation
A test item was considered irritant in the in vitro eye irritation test if:
-The relative mean tissue viability of three individual tissues after exposure to the test item is ≤ 60% ± 5% of the mean viability of the negative controls.
A test item was considered non-irritant in the in vitro eye irritation test if:
-The relative mean tissue viability of three individual tissues after exposure to the test item is > 60% ± 5% of the mean viability of the negative controls.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: Relative mean tissue viability
- Run / experiment:
- Mean of two replicates
- Value:
- 126.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
For individual results see Table 1 in box "Any other information on results incl. tables".
Any other information on results incl. tables
Preliminary assessment
CD08467 (test substance) were checked for possible direct MTT reduction by adding the test substances to MTT medium. Because no colour change was observed, it was concluded that CD08467 (test substance) did not interact with MTT. CD08467 (test substance) was checked to identify potential interference by test item absorbing light in the same range as MTT formazan (naturally or after treatment) by adding the test substance to water and ispopropanol. Optical densities measured after mixing CD08467 with water or isproponal were lower than 0.08, showing no interference.
Table 1: Mean absorption in the in vitro eye irritation test with test item, and positive and negative controls
Blank |
|
|
Difference of viability |
Negative control |
Mean OD |
1.187 |
0.0% |
Mean Viability |
100% |
||
Positive Control |
Mean OD |
0.431 |
5.2% |
Mean Viability |
36.3% |
||
CD08467 |
Mean OD |
1.505 |
34.4% |
Mean Viability |
126.8% |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study under the given conditions the test item CD08467 showed no irritant effects. The test item is classified as “non-irritant“ in accordance with UN GHS “No Category” for eye irritation.
- Executive summary:
In the present study the eye irritation potential of CD08467 (99.1% purity) was analysed according to OECD 492 using the three-dimensional RhCE tissue, consisting of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo.
Hereby, 50 mg of the test item was applied directly atop the EpiOcular™ tissue. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 6-hour exposure and 18-hour post-incubation period and compared to those of the concurrent negative controls. CD08467 (test substance) was checked for possible direct MTT reduction by adding the test substances to MTT medium. Since no colour change was observed, it was concluded that the test substance did not interact with MTT. In addition, the test substance was checked to identify potential interference by absorbing light in the same range as MTT formazan (naturally or after treatment). The test substance was added to water and isopropanol and the measured optical densities were lower than 0.08, showing no interference.
The mean cell viability of positive control was less than 50% and the difference in viability between the two tissues was less than 20 %, indicating that the test system functioned properly. The relative mean tissue viability (126.8%) obtained after 6 hours of treatment with the test substance compared to the negative control tissues (100%) showed no irritation. In conclusion, under the experimental conditions of this in vitro eye irritation test, the test item is considered to be non-irritating to the eye in accordance with UN GHS “No Category”.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)